These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42 related articles for article (PubMed ID: 17884792)
1. [Application of liquid-based cytology and high-risk human papillomavirus DNA detection in cervical lesion screening]. Wu D; Ding L; Wu JH; Li ZN Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1421-3. PubMed ID: 17884792 [TBL] [Abstract][Full Text] [Related]
2. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer. Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934 [TBL] [Abstract][Full Text] [Related]
3. [Significance of human papillomavirus test in triage of patients with atypical squamous cell of undetermined significance]. Zhao J; Zhou JN; Yang YJ; Liao QP Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):299-301. PubMed ID: 19105350 [TBL] [Abstract][Full Text] [Related]
4. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion]. Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634 [TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix. Hall S; Lörincz A; Shah F; Sherman ME; Abbas F; Paull G; Kurman RJ; Shah KV Gynecol Oncol; 1996 Sep; 62(3):353-9. PubMed ID: 8812532 [TBL] [Abstract][Full Text] [Related]
6. [Value assessment of high-risk HPV test and TCT in the screening of cervical carcinoma]. Sun XF; Gu YQ; Wang AC; Wang J; Xie JL Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Aug; 27(4):273-6. PubMed ID: 24579473 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening. Ekalaksananan T; Pientong C; Sriamporn S; Kongyingyoes B; Pengsa P; Kleebkaow P; Kritpetcharat O; Parkin DM Gynecol Oncol; 2006 Oct; 103(1):62-6. PubMed ID: 16494930 [TBL] [Abstract][Full Text] [Related]
8. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS). Walker JL; Wang SS; Schiffman M; Solomon D; Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545 [TBL] [Abstract][Full Text] [Related]
9. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities]. Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425 [TBL] [Abstract][Full Text] [Related]
10. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136 [TBL] [Abstract][Full Text] [Related]
11. Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay. Halfon P; Benmoura D; Agostini A; Khiri H; Martineau A; Penaranda G; Blanc B J Clin Virol; 2010 Feb; 47(2):177-81. PubMed ID: 20022804 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials. Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254 [TBL] [Abstract][Full Text] [Related]
13. MALDI imaging as a specific diagnostic tool for routine cervical cytology specimens. Schwamborn K; Krieg RC; Uhlig S; Ikenberg H; Wellmann A Int J Mol Med; 2011 Mar; 27(3):417-21. PubMed ID: 21174066 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix. Munkhdelger J; Choi Y; Lee D; Kim S; Kim G; Park S; Choi E; Jin H; Jeon BY; Lee H; Park KH Diagn Microbiol Infect Dis; 2014 Aug; 79(4):422-7. PubMed ID: 24856365 [TBL] [Abstract][Full Text] [Related]
15. [The study of combining high-risk human papillomavirus types checking and cytologic test in the screening of cervical lesions]. Xu XH; Xie ZX; Ma R; Zhang WQ; Li QF Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):298-300. PubMed ID: 22097613 [TBL] [Abstract][Full Text] [Related]
16. [Evaluation of genotyping of human papilomavirus by a new DNA liquid chip based on Luminex XMAP]. Deng XM; Liu M; Zheng GX; Wang CX; Zhang J; Li W Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec; 23(6):476-8. PubMed ID: 20718362 [TBL] [Abstract][Full Text] [Related]
17. Mitochondrial DNA mutations in patients with HRHPV-related cervical lesions. Goia-Ruşanu CD; Iancu IV; Botezatu A; Socolov D; Huică I; Pleşa A; Anton G Roum Arch Microbiol Immunol; 2011; 70(1):5-10. PubMed ID: 21717805 [TBL] [Abstract][Full Text] [Related]
18. [High-risk human papilloma virus DNA detection kit (cervista HPV HR) should be highly validated clinically in cervical cancer screening programs]. Zhao J; Zhang XG; Chen R; Bi H; Wang X; Liu GW; Yao DX; Zong Y; Liao QP Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):149-51. PubMed ID: 21863645 [TBL] [Abstract][Full Text] [Related]
19. Outcomes of women with atypical squamous cells of undetermined significance and high-risk human papillomavirus DNA. Feng J; Husain M Acta Cytol; 2007; 51(5):730-4. PubMed ID: 17910342 [TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus testing and cervical cytology in primary screening for cervical cancer among women in rural China: comparison of sensitivity, specificity, and frequency of referral. Moy LM; Zhao FH; Li LY; Ma JF; Zhang QM; Chen F; Song Y; Hu SY; Balasubramanian A; Pan QJ; Koutsky L; Zhang WH; Lim JM; Qiao YL; Sellors JW Int J Cancer; 2010 Aug; 127(3):646-56. PubMed ID: 19960441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]